FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for Nortriptyline Hydrochloride (PAI Pharma) under ANDA075606. The action grants approval of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Nortriptyline Hydrochloride (Nortriptyline hydrochloride)

Snippet

SUPPL AP for NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE HYDROCHLORIDE)